0001415889-24-007392.txt : 20240308 0001415889-24-007392.hdr.sgml : 20240308 20240308173543 ACCESSION NUMBER: 0001415889-24-007392 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tom Penny CENTRAL INDEX KEY: 0002012180 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38692 FILM NUMBER: 24735773 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA, SUITE 105 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Equillium, Inc. CENTRAL INDEX KEY: 0001746466 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821554746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 105 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 412-5302 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 105 CITY: LA JOLLA STATE: CA ZIP: 92037 3 1 form3-03082024_100338.xml X0206 3 2024-03-06 0 0001746466 Equillium, Inc. EQ 0002012180 Tom Penny 2223 AVENIDA DE LA PLAYA, SUITE 105 LA JOLLA CA 92037 false true false false Principal Accounting Officer Common Stock 33857 D Employee Stock Option (right to buy) 2.45 2029-01-30 Common Stock 65000 D Employee Stock Option (right to buy) 2.45 2029-12-09 Common Stock 45000 D Employee Stock Option (right to buy) 5.03 2031-01-03 Common Stock 40000 D Employee Stock Option (right to buy) 3.86 2032-01-18 Common Stock 60000 D Employee Stock Option (right to buy) 2.52 2032-05-01 Common Stock 40000 D Employee Stock Option (right to buy) 1.06 2033-01-02 Common Stock 100000 D Employee Stock Option (right to buy) 0.73 2034-01-01 Common Stock 100000 D Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Effective as of August 14, 2023, the Company's board of directors approved the repricing of the options to an exercise price of $0.785 per share. However, if a repriced option is exercised prior to the Retention Period End Date (as defined in Item 5 of the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023, filed with the SEC on August 9, 2023), or the optionholder's employment or service terminates under certain circumstances prior to the Retention Period End Date, the optionholder will be required to pay a premium price equivalent to the original exercise price per share of the repriced options. Such original exercise price per share is reflected in this column. /s/ Penny Tom 2024-03-06 EX-24 2 ex24-03082024_100339.htm ex24-03082024_100339.htm








LIMITED POWER OF ATTORNEY

FOR

SECTION 16(a) FILINGS

Know all by these presents, that the undersigned hereby constitutes and appoints each of Bruce D. Steel and Jason A. Keyes, signing individually, as the undersigned's true and lawful attorney-in-fact to:


(1)

Execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or stockholder of Equillium, Inc. (the “Company”), Forms 3, 4, and 5 and amendments thereto in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules thereunder;

(2)

Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 or amendment thereto and timely file such form with the United States Securities and Exchange Commission (the “SEC”) and any stock exchange or similar authority; and

(3)

Take any other action of any type whatsoever which, in the opinion of any such attorney-in-fact, may be necessary or desirable in connection with the foregoing authority, it being understood that the documents executed by and such attorney- in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.


The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorney-in-facts, in serving in such capacity at the request of the undersigned, is not assuming, nor is any Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.


This Limited Power of Attorney shall remain in full force and effect until the earlier to occur of (a) undersigned is no longer required to file Forms 3, 4, and 5 with respect to any securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and (c) as to any attorney-in-fact individually, until such attorney-in- fact is no longer employed by the Company. This Limited Power of Attorney may be filed with the SEC as a confirming statement of the authority granted herein.


[Signature Page Follows]












IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be


executed as of February 8, 2024.


/s/ Penny Tom


Penny Tom